“…Recent studies indicated that small post‐procedural elevations in serum creatinine (≥0.3 mg/dL) portray a bad prognosis, which lead to novel AKI classifications accounting for these tiny changes. In this issue of Catheterization and Cardiovascular Interventions , Koifman et al report the results of a single‐center, observational study elucidating the predictors of two currently used AKI classifications and their prognostic value in 217 patients undergoing TAVI: (a) The RIFLE ( the Risk, Injury, Failure, Loss, and End‐stage Kidney ), thoroughly evaluated since its introduction in 2002 and (b) the KDIGO ( Kidney Disease: Improving Global Outcomes ) from the VARC‐2 ( Valve Academic Research Consortium‐2 ) . In the current study, AKI rates were 21% with the RIFLE (grade I: 17% and grade III: 0.5%) and 23% with the KDIGO/VARC‐2 classification (grade I: 18%, and grade III: 0.5%), while the discordance between classifications was only 10% .…”